Chromosomal instability drives metastasis through a cytosolic DNA response

Cited by (1,551)

Items 301–400 of 1,551

1. CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
   Cerise Yuen‐Ki Chan, David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, Cheuk‐Ting Law, Bowie Po‐Yee Wong, Kelsie L. Thu, David W. Cescon, Isabel Soria‐Bretones, Jacinth Wing‐Sum Cheu, Derek Lee et al. · 2022 · Proceedings of the National Academy of Sciences
2. Aneuploidy and complex genomic rearrangements in cancer evolution
   Toby M. Baker, Sara Waise, Maxime Tarabichi, Peter Van Loo · 2024 · Nature Cancer
3. STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
   Laura Gehrcken, Christophe Deben, Evelien Smits, Jonas R.M. Van Audenaerde · 2025 · Advanced Science
4. Opportunities and challenges of targeting cGAS–STING in cancer
   Changzheng Lu, Wenyan Wang, Yang‐Xin Fu · 2026 · Nature reviews. Cancer
5. The Many Roles of Ubiquitin in NF-κB Signaling
   Gilles Courtois, Marie‐Odile Fauvarque · 2018 · Biomedicines
6. Structural Insights into STING Signaling
   Sabrina L. Ergun, Lingyin Li · 2020 · Trends in Cell Biology
7. High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer Corrigendum in /10.3892/ijo.2021.5213
   Zhibin Liao, Hongwei Zhang, Pan Fan et al. · 2018 · International Journal of Oncology
8. STING Signaling and Sterile Inflammation
   Isabelle Couillin, Nicolas Riteau · 2021 · Frontiers in Immunology
9. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
   Yoann Pradat, Julien Viot, Гунбин Константин Владимирович, Гунбин Константин Владимирович, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loïc Verlingue, Véronique Scott, Ismaël Padioleau et al. · 2023 · Cancer Discovery
10. TRABID inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation
    Yu-Hsuan Chen, Han-Hsiun Chen, Won‐Jing Wang, Hsin‐Yi Chen, Wei-Syun Huang, Chien-Han Kao, Sin-Rong Lee, Nai Yang Yeat, Ruei-Liang Yan, Shu-Jou Chan et al. · 2023 · Nature Communications
11. cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer
    Mengting Chen, Shibo Yu, Tineke van der Sluis, Mieke C. Zwager, Carolien P. Schröder, Bert van der Vegt, Marcel A.T.M. van Vugt · 2024 · npj Breast Cancer
12. Recruitment of DNA to tumor-derived microvesicles
    James W. Clancy, Colin S. Sheehan, Alex C. Boomgarden, Crislyn D’Souza‐Schorey · 2022 · Cell Reports
13. cGAS–STING signalling in cancer: striking a balance with chromosomal instability
    Bruno Beernaert, Eileen E. Parkes · 2023 · Biochemical Society Transactions
14. Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment
    Dhanya K. Nambiar, Vignesh Viswanathan, Hongbin Cao, Weiruo Zhang, Li Guan, Manish Chamoli, Brittany Holmes, Christina S. Kong, Rachel Hildebrand, Amanda Jeanette Koong et al. · 2023 · Cancer Research
15. Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements
    Ksenia Krupina, Alexander Goginashvili, Don W. Cleveland · 2023 · Nature Reviews Genetics
16. Tetraploidy in cancer and its possible link to aging
    Kozo Tanaka, Hidemasa Goto, Yuhei Nishimura, Kousuke Kasahara, Akira Mizoguchi, Masaki Inagaki · 2018 · Cancer Science
17. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response
    Mei Zhao, Tianxiao Wang, Frederico O. Gleber‐Netto, Zhen Chen, Daniel James McGrail, Javier A. Gomez, Wu‐tong Ju, Mayur A. Gadhikar, Wencai Ma, Li Shen et al. · 2024 · Nature Communications
18. The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability
    Christy Hong, Andréa E. Tijhuis, Floris Foijer · 2019 · Cells
19. Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy
    Yaling Dou, Rui Chen, Siyao Liu, Yi‐Tsang Lee, Jing Ji, Xiaoxuan Liu, Yuepeng Ke, Rui Wang, Yubin Zhou, Yun Huang · 2023 · Nature Communications
20. Cell-in-Cell Phenomenon and Its Relationship With Tumor Microenvironment and Tumor Progression: A Review
    Xinlong Wang, Yilong Li, Jiating Li, Le Li, Hong‐Jian Zhu, Hua Chen, Rui Kong, Gang Wang, Yongwei Wang, Jisheng Hu et al. · 2019 · Frontiers in Cell and Developmental Biology
21. Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis
    Kaiwen Zhang, Dong Liu, Jianmei Zhao, Si Shi, Xin He, Peng Da, Yiwen You, Bo You · 2021 · Cell Death and Disease
22. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
    Mathieu F. Bakhoum, Jasmine H. Francis, Albert S. Agustinus, Ethan M. Earlie, Melody Di Bona, David H. Abramson, Mercedes A. Duran Paez, Ignas Masilionis, Elsa Molina, Alexander Noor Shoushtari et al. · 2021 · Nature Communications
23. Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
    Lavinia Anne Spain, Alexander Coulton, Irene Lobón, Andrew Rowan, Désirée Schnidrig, Scott T.C. Shepherd, Benjamin Shum, Fiona Byrne, Maria Goicoechea, Elisa Piperni et al. · 2023 · Cancer Discovery
24. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements
    Sara Martin, Simone Scorzoni, Sara Cordone, Alice Mazzagatti, Galina V. Beznoussenko, Amanda Gunn, Melody Di Bona, Yonatan Eliezer, Gil Leor, Tal Ben-Yishay et al. · 2024 · Science
25. Tumor grafted – chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation
    Ana Katrina Mapanao, Pei Pei Che, Patrizia Sarogni, Peter Sminia, Elisa Giovannetti, Valerio Voliani · 2021 · Expert Opinion on Drug Metabolism & Toxicology
26. AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer
    Zikun Ma, Zhiyong Li, Yize Mao, Jingwei Ye, Zefu Liu, Yuzhao Wang, Chen Wei, Jun Cui, Zhuowei Liu, Xiaoyu Liang · 2023 · Nature Communications
27. The interplay between autophagy and cGAS-STING signaling and its implications for cancer
    Maximilian Schmid, Patrick Fischer, Magdalena Engl, Joachim Widder, Sylvia Gruber, Dea Slade · 2024 · Frontiers in Immunology
28. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
    Suzy Scholl, Marina Popović, Anne de la Rochefordière, Elodie Girard, Sylvain Dureau, Aljoša Mandić, Katarina Koprivšek, Nina Samet, Marius Lucian Craina, Mădălin-Marius Margan et al. · 2019 · EBioMedicine
29. The Innate Immune Signalling Pathways: Turning RIG-I Sensor Activation against Cancer
    Sandra Iurescia, Daniela Fioretti, Monica Rinaldi · 2020 · Cancers
30. Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
    Lindsay N. Redman, Timothy M. Shaver, Hailing Jin, Clayton B. Marshall, Johanna M. Schafer, Quanhu Sheng, Rachel A. Hongo, Kathryn Eby Beckermann, Ferrin C. Wheeler, Brian David Lehmann et al. · 2021 · Nature Communications
31. Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy
    Ruijie Liang, Yu Chen, Minfeng Huo, Jun Zhang, Yongsheng Li · 2019 · Nanoscale Horizons
32. Fusion-mediated chromosomal instability promotes aneuploidy patterns that resemble human tumors
    Lucile Delespaul, Candice Merle, Tom Lesluyes, Pauline Lagarde, Sophie Le Guellec, Gaëlle Pérot, Jessica Baud, Martina Carlotti, Coralie Danet, Murielle Fèvre et al. · 2019 · Oncogene
33. Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
    Johanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, Giuseppina De Feudis, Eli Reuveni, Anouk Savir Kadmon, Sara Martin, Sonia Viganò, Gil Leor, James Berstler et al. · 2024 · Nature Communications
34. TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survival
    Pauline Lascaux, Gwendoline Hoslett, Sara Tribble, Camilla Trugenberger, Ivan Antičević, Cécile Otten, Ignacio Torrecilla, Stelios Koukouravas, Yichen Zhao, Hongbin Yang et al. · 2024 · Cell
35. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond
    Frédéric Chibon, Tom Lesluyes, Thibaud Valentin, Sophie Le Guellec · 2018 · Genes Chromosomes and Cancer
36. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells
    Kritarth Singh, Milton Roy, Paresh Prajapati, Anastasiya V. Lipatova, Lakshmi Sripada, Dhruv Gohel, Aru Singh, Meenal Mane, Madan Madhav Godbole, Peter M. Chumakov et al. · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
37. Small‐molecule inhibition of aging‐associated chromosomal instability delays cellular senescence
    Monika Barroso‐Vilares, Joana Catarina Macedo, M. Reis, Jessica D. Warren, Duane A. Compton, Elsa Logarinho · 2020 · EMBO Reports
38. Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair
    Rui R Liu, Jingyi Li, Jichun Shao, Jong-Ho Lee, Xuemei Qiu, Yanxuan Xiao, Bowen Zhang, Yilong Hao, Mi Li, Qianming Chen · 2021 · Cell Metabolism
39. cGAS‐STING pathway: post‐translational modifications and functions in sterile inflammatory diseases
    Ze Hong, Tianchi Ma, Xing Liu, Chen Wang · 2021 · FEBS Journal
40. Enterococcus spp.: Is It a Bad Choice for a Good Use—A Conundrum to Solve?
    Mounir Ferchichi, Khaled Sebei, Amine M. Boukerb, Najoua Karray‐Bouraoui, Sylvie Chevalier, Marc G. J. Feuilloley, Nathalie Connil, Mohamed Zommiti · 2021 · Microorganisms
41. Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion
    Wang Gong, Christopher R. Donnelly, Blake R. Heath, Emily Light Bellile, Lorenza A. Donnelly, Hülya F. Taner, Luke J. Broses, John Chad Brenner, Steven Bennett Chinn, Ru‐Rong Ji et al. · 2021 · OncoImmunology
42. Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA –Associated Pancreatic Cancer in the Clinical and Preclinical Setting
    Chani Stossel, Maria Raitses‐Gurevich, Dikla Atias, Tamar Beller, Yulia Glick Gorman, Sharon Halperin, Eyal Peer, Robert Edward Denroche, Amy Xin Wei Zhang, Faiyaz Notta et al. · 2023 · Cancer Discovery
43. Targeting STING in cancer: Challenges and emerging opportunities
    Kexin Zhao, Jiaojiao Huang, Yue Zhao, Shengjun Wang, Juan Xu, Kai Yin · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
44. Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
    Adrienne Sallets, Sophie Robinson, Adel Kardosh, Ronald Levy · 2018 · Blood Advances
45. Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects
    Nidhan K. Biswas, Chitrarpita Das, Subrata Kumar Das, Arindam Maitra, Sudhir Vasudevan Nair, Tejpal Gupta, Anil Keith Dcruz, Rajiv Sarin, Partha Pratim Majumder · 2019 · International Journal of Cancer
46. Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial
    Priyanka Sharma, William Eric Barlow, Andrew K. Godwin, Eileen E. Parkes, Laura A. Knight, Steven M. Walker, Richard D. Kennedy, Denis Paul Harkin, Gemma E. Logan, Christopher Steele et al. · 2019 · Journal of Clinical Oncology
47. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis
    Swadesh Kumar Das, Santanu Maji, Stephen L. Wechman, Praveen Bhoopathi, Anjan K. Pradhan, Sarmistha Talukdar, Devanand Sarkar, Joseph W. Landry, Chunqing Guo, Xiang‐Yang Wang et al. · 2020 · Pharmacological Research
48. Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway
    Maria Krivega, Clara M. Stiefel, Sahar Karbassi, Line Lykke Andersen, Narendra Kumar Chunduri, Neysan Donnelly, Andreas Pichlmair, Zuzana Štorchová · 2021 · Communications Biology
49. cGAMP the travelling messenger
    Henry T.W. Blest, Lise Chauveau · 2023 · Frontiers in Immunology
50. STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)
    Jiale Liu, Chenmian Liu, Yana Ma, Xiyu Pan, Ran Chu, Shu Yao, Junyu Chen, Chang Liu, Zhongshao Chen, Chenchen Sheng et al. · 2024 · Cancer Letters
51. Tolerance of Chromosomal Instability in Cancer: Mechanisms and Therapeutic Opportunities
    Eva Camilla Gronroos, Carlos López-García · 2018 · Cancer Research
52. Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer
    Victoria H. Cruz, Emily Nicole Arner, Wenting Du, Alberto E. Bremauntz, Rolf A. Brekken · 2019 · JCI Insight
53. Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. ‘cannabinoid exposure and altered DNA methylation in rat and human sperm’ epigenetics 2018; 13: 1208-1221.
    Albert Stuart Reece, Gary Kenneth Hulse · 2019 · Epigenetics
54. The abscopal effect: a sense of DNA damage is in the air
    Timothy P. Lippert, Roger A. Greenberg · 2021 · Journal of Clinical Investigation
55. The SCF Complex Is Essential to Maintain Genome and Chromosome Stability
    Laura L. Thompson, Kailee A. Rutherford, Chloe C. Lepage, Kirk James McManus · 2021 · International Journal of Molecular Sciences
56. All is not lost: learning from 9p21 loss in cancer
    Pavlina Spiliopoulou, S.Y. Cindy Yang, Jeff P. Bruce, Ben X. Wang, Hal K. Berman, Trevor J. Pugh, Lillian L. Siu · 2022 · Trends in Immunology
57. Updated roles of cGAS-STING signaling in autoimmune diseases
    Ya Liu, Feifei Pu · 2023 · Frontiers in Immunology
58. BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
    Ying L. Liu, Pier Selenica, Qin C Zhou, Alexia E. Iasonos, Margaret K. Callahan, Noah Z. Feit, Julia L. Boland, Ignacio Vázquez-Garćıa, Diana L. Mandelker, Ahmet Zehir et al. · 2020 · JCO Precision Oncology
59. Deep learning predicts chromosomal instability from histopathology images
    Zhuoran Xu, Akanksha Verma, Uska Naveed, Samuel F. W. Bakhoum, Pegah Khosravi, Olivier Elemento · 2021 · iScience
60. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets
    Jun Lu, Yongfeng Ding, Yanyan Chen, Junjie Jiang, Yiran Chen, Yingying Huang, Mengjie Wu, Chengzhi Li, Mei Kong, Wenyi Zhao et al. · 2021 · Nature Communications
61. Modification of BRCA1-associated breast cancer risk by HMMR overexpression
    Francesca Mateo, Zhengcheng He, Lin Mei, Gorka Ruiz de Garibay Ponce, Carmen Herranz, Nadia García, Amanda C. Lorentzian, Alexandra Baiges, Eline Blommaert, Antonio Gómez et al. · 2022 · Nature Communications
62. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)
    Christine Song, Val J. Lowe, SeungBaek Lee · 2021 · Breast Cancer
63. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
    Renske J.E. van den Bijgaart, Fabian Schuurmans, Jurgen J. Fütterer, Marcel Verheij, Lenneke A. M. Cornelissen, Gosse J. Adema · 2021 · Frontiers in Immunology
64. Nuclear deformations, from signaling to perturbation and damage
    Guilherme P. F. Nader, Alice Williart, Matthieu Piel · 2021 · Current Opinion in Cell Biology
65. Cancer immunotherapy strategies that target the cGAS-STING pathway
    Zhuoying Tian, Yue Zeng, Yurong Peng, Junqi Liu, Fang Wu · 2022 · Frontiers in Immunology
66. Pan-cancer human brain metastases atlas at single-cell resolution
    Xudong Xing, Jian Zhong, Jana Biermann, Hao Duan, Xinyu Zhang, Yu Shi, Yixin Gao, Kejun He, Duanyang Zhai, Feng Luo et al. · 2025 · Cancer Cell
67. The frequencies of micronuclei, nucleoplasmic bridges and nuclear buds as biomarkers of genomic instability in patients with urothelial cell carcinoma
    Arjeta Podrimaj-Bytyqi, Ana Borovečki, QERIM ISAK SELIMI, Suzana Manxhuka-Kërliu, Goneta Gashi, Isa R. Elezaj · 2018 · Scientific Reports
68. DNA Methylation of Shelf, Shore and Open Sea CpG Positions Distinguish High Microsatellite Instability from Low or Stable Microsatellite Status Colon Cancer Stem Cells
    Rosa Visone, Maria Giulia Bacalini, Simone Di Franco, Manuela Ferracin, Maria Luisa Colorito, Sara Pagotto, Noemi Laprovitera, Danilo Licastro, Mirco Di Marco, Emanuela Scavo et al. · 2019 · Epigenomics
69. Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease
    Sarah A. Joseph, Angelo Taglialatela, Giuseppe Leuzzi, Jen‐Wei Huang, Raquel Cuella-Martin, Alberto Ciccia · 2020 · DNA repair
70. Targeting TANK-binding kinase 1 (TBK1) in cancer
    Or‐Yam Revach, Shuming Liu, Russell William Jenkins · 2020 · Expert Opinion on Therapeutic Targets
71. Radionuclide Therapy in Prostate Cancer: From Standalone to Combination PSMA Theranostics
    Shahneen Kaur Sandhu, Christina W. Guo, Michael S. Hofman · 2021 · Journal of Nuclear Medicine
72. Aurora B Tension Sensing Mechanisms in the Kinetochore Ensure Accurate Chromosome Segregation
    Shelby L. McVey, Jenna K. Cosby, Natalie J. Nannas · 2021 · International Journal of Molecular Sciences
73. Chromosome length and gene density contribute to micronuclear membrane stability
    Anna Mammel, Heather Z Huang, Amanda Gunn, Emma Choo, Emily M. Hatch · 2021 · Life Science Alliance
74. Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations
    Leilei Wu, Zhenshan Zhang, Menglin Bai, Yujie Yan, Jinming Yu, Yaping Xu · 2023 · Cell Communication and Signaling
75. Regulation and function of the cGAS-MITA/STING axis in health and disease
    Zhi-Dong Zhang, Bo Zhong · 2022 · Cell Insight
76. The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
    Jaromir Hunia, Karol Gawalski, Aleksandra Szredzka, Marcin J. Suskiewicz, Dominika Nowis · 2022 · Frontiers in Molecular Biosciences
77. IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
    He Xu, Abdalla M. Wedn, Jian Wang, Yanlun Gu, Hongjin Liu, Juqi Zhang, Zhiqiang Lin, Renpeng Zhou, Xiaocong Pang, Yimin Cui · 2024 · Pharmacological Research
78. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
    Andrew McPherson, Ignacio Vázquez-Garćıa, Matthew A. Myers, Duaa Hassan Al-Rawi, Matthew Zatzman, Adam C. Weiner, Samuel S. Freeman, Neeman Mohibullah, Gryte Satas, Marc J. Williams et al. · 2025 · Nature
79. Cancer: a CINful evolution
    Altea Targa, Giulia Irene Rancati · 2018 · Current Opinion in Cell Biology
80. Molecular cytogenetics of the micronucleus: Still surprising
    Antonella Russo, Francesca Degrassi · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
81. Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
    Alice Y. Ho, Jean L. Wright, Rachel C. Blitzblau, Robert W. Mutter, Dan Gabriel Duda, Larry Norton, Aditya Bardia, Laura M. Spring, Steven Jay Isakoff, Jonathan H. Chen et al. · 2020 · International Journal of Radiation Oncology*Biology*Physics
82. DNA hypomethylation leads to cGAS‐induced autoinflammation in the epidermis
    Mirjam A Beck, Heinz Fischer, Lisa Grabner, Tamara Groffics, Mircea Winter, Simone Tangermann, Tina Meischel, Barbara Zaussinger‐Haas, Patrick Wagner, Carina Fischer et al. · 2021 · The EMBO Journal
83. Death and survival from executioner caspase activation
    Gongping Sun · 2023 · Seminars in Cell and Developmental Biology
84. Whole-genome doubling in tissues and tumors
    Marc A. Vittoria, Ryan J. Quinton, Neil J. Ganem · 2023 · Trends in Genetics
85. ER: a critical hub for STING signaling regulation
    Yuan Luo, Lei Chang, Yewei Ji, Tingbo Liang · 2024 · Trends in Cell Biology
86. Inflammatory signaling in genomically instable cancers
    Francien Talens, Marcel A.T.M. van Vugt · 2019 · Cell Cycle
87. STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway
    Laura Cheradame, Ida Chiara Guerrera, Julie Gaston, Alain Schmitt, Vincent A. Jung, Nicolas Goudin, Marion Pouillard, Nina Radosevic‐Robin, Mauro Modesti, Jean‐Gabriel Judde et al. · 2021 · Oncogene
88. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
    Vanja Tadić, Wei Zhang, Anamaria Brozović · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
89. Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN
    Eléonore Toufektchan, Alexandra Dananberg, Josefine Striepen, James H. Hickling, Abraham Shim, Yanyang Chen, Ashley Nichols, Mercedes A. Duran Paez, Lisa Mohr, Samuel F. Bakhoum et al. · 2024 · Cancer Immunology Research
90. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance
    Ankur K. Singh, Ilana Brito, Jan Lammerding · 2018 · Trends in cancer
91. Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
    Björn Hiller, Anja Hoppe, Christa Haase, Christina Hiller, Nadja Schubert, Werner Müller, Martin A.M. Reijns, Andrew P. Jackson, Thomas A. Kunkel, Joerg Wenzel et al. · 2018 · Cancer Research
92. Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes
    Clara Taffoni, Alizée Steer, Johanna Marines, Hanane Chamma, Isabelle K. Vila, Nadine Laguette · 2021 · Frontiers in Immunology
93. Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour
    Seung‐hwan Jeong, Myung Jin Yang, Seunghyeok Choi, JungMo Kim, Gou Young Koh · 2021 · Nature Communications
94. Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
    Ornella Franzese, Grazia Graziani · 2022 · Cancers
95. Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects
    Yanxiang Cheng, Zhen Qu, Qian Jiang, Tingting Xu, Hongyun Zheng, Peng Ye, Mingdi He, Yongqing Tong, Yan Ma, Anyu Bao · 2023 · Advanced Materials
96. Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint
    Rachel E. Mardjuki, Songnan Wang, Jacqueline A. Carozza, Bahar Zirak, Vishvak Subramanyam, Gita C. Abhiraman, Xuchao Lyu, Hani Goodarzi, Lingyin Li · 2024 · Cell Reports
97. Genomic instability as a driver and suppressor of anti-tumor immunity
    Marta Requesens, Floris Foijer, Hans W. Nijman, Marco de Bruyn · 2024 · Frontiers in Immunology
98. Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy
    Weiyue Zhang, Xin Huang · 2025 · Biomarker Research
99. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1
    Cheng Zhang, Like Qu, Shenyi Lian · 2018 · Cancer Research
100. Understanding the birth of rupture-prone and irreparable micronuclei
     Xihan Guo, Xueqin Dai, Xue Wu, Tao Zhou, Juan Ni, Jinglun Xue, Xu Wang · 2020 · Chromosoma